Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Oct 5, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 413
- Market value to sell
- $1.41B
- Sellers
- 117
- Companies
- 37
- Under 10b5-1 plans
- 220
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| VIRVir Biotechnology, Inc. | Feb 23, 20264:34 PM ET | Eisner MarkOfficer | 2.09K | $15.6K | Feb 23, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 23, 20264:32 PM ET | De Backer MarianneOfficer ยท Director | 19.0K | $141.9K | Feb 23, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 23, 20264:22 PM ET | de Verneuil VaninaOfficer | 4.45K | $33.1K | Feb 23, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 23, 20264:18 PM ET | Sabatini BrentOfficer | 1.83K | $13.6K | Feb 23, 2026 | Fidelity Brokerage Services LLC | SEC |
| KRYSKrystal Biotech, Inc. | Feb 19, 202612:09 PM ET | Rossi Dino ADirector | 18.9K | $4.95M | Feb 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Feb 19, 202611:03 AM ET | Menon RajeevOfficer | 3.49K | $1.24M | Feb 19, 2026 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Feb 19, 20269:56 AM ET | Boulding Mark ElliottOfficer | 3.02K | $207.0K | Feb 19, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Feb 18, 20264:38 PM ET | Boulding Mark ElliottOfficer | 3.08K | $213.7K | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Feb 18, 20262:22 PM ET | Breland Benjamin T.Officer | 2.00K | $716.1K | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| FTHFaeth Therapeutics, Inc. | Feb 18, 20261:22 PM ET | Peyer JamesFomer Director | 950 | $25.8K | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Feb 18, 20261:19 PM ET | Brown William POfficer | 9.46K | $3.39M | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Feb 18, 202612:30 PM ET | Oberg Kathleen K.Officer | 12.8K | $4.55M | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Feb 18, 202611:28 AM ET | Menon RajeevOfficer | 6.33K | $2.26M | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Feb 17, 20263:29 PM ET | Capuano AnthonyOfficer ยท Director | 63.0K | $22.4M | Feb 17, 2026 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Feb 17, 20263:08 PM ET | Pinto DrewOfficer | 4.00K | $1.44M | Feb 17, 2026 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Feb 17, 202612:51 PM ET | Boulding Mark ElliottOfficer | 2.81K | $194.5K | Feb 17, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Feb 17, 202610:52 AM ET | Marriott David SChairman of The Board | 4.75K | $1.60M | Feb 17, 2026 | Raymond James & Associates, Inc. | SEC |
| MARMarriott International Inc | Feb 13, 20264:24 PM ET | Oberg Kathleen K.Officer | 4.88K | $1.74M | Feb 13, 2026 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Feb 13, 20263:49 PM ET | Reiss Rena HozoreOfficer | 2.51K | $896.8K | Feb 13, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 13, 20263:46 PM ET | Sabatini BrentOfficer | 1.53K | $11.9K | Feb 13, 2026 | Fidelity Brokerage Services LLC | SEC |
| CLColgate Palmolive Co | Feb 12, 20264:30 PM ET | Tsourapas PanagiotisOfficer | 15.0K | $1.47M | Feb 12, 2026 | Merrill Lynch | SEC |
| CLColgate Palmolive Co | Feb 11, 20264:05 PM ET | Tsourapas PanagiotisOfficer | 35.0K | $3.31M | Feb 11, 2026 | Merrill Lynch | SEC |
| KRYSKrystal Biotech, Inc. | Feb 9, 20264:04 PM ET | Romano KathrynOfficer | 12.5K | $3.46M | Feb 9, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| LBRTLiberty Energy Inc. | Feb 6, 20264:02 PM ET | Elliott R SeanOfficer | 25.0K | $635.0K | Feb 6, 2026 | Charles Schwab & Co., Inc. | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Feb 4, 20264:52 PM ET | Patrick BurnettOfficer | 9.79K | $252.7K | Feb 4, 202610b5-1 | Merrill Lynch | SEC |
| ADPTAdaptive Biotechnologies Corp | Feb 3, 20265:09 PM ET | Harlan RobinsOfficer | 8.12K | $150.2K | Feb 3, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Feb 2, 20266:19 PM ET | Masaru MatsudaOfficer | 40.6K | $1.03M | Feb 2, 202610b5-1 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Feb 2, 20266:17 PM ET | Todd EdwardsOfficer | 2.05K | $52.3K | Feb 2, 2026 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Feb 2, 20266:15 PM ET | Latha VairavanOfficer | 1.32K | $33.7K | Feb 2, 2026 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Feb 2, 20265:48 PM ET | Patrick BurnettOfficer | 3.67K | $93.7K | Feb 2, 2026 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Feb 2, 20265:41 PM ET | Todd Frank WatanabeOfficer | 19.8K | $505.7K | Feb 2, 2026 | Merrill | SEC |
| AXSMAxsome Therapeutics, Inc. | Feb 2, 20265:30 PM ET | Herriot TabuteauOfficer | 32.4K | $6.02M | Feb 2, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Feb 2, 20265:26 PM ET | Harlan RobinsOfficer | 34.7K | $637.5K | Feb 2, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Feb 2, 20265:24 PM ET | Chad RobinsOfficer | 125.0K | $2.30M | Feb 2, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Feb 2, 20265:04 PM ET | Howard WelgusDirector | 10.0K | $250.5K | Feb 2, 202610b5-1 | Merrill | SEC |
| FTHFaeth Therapeutics, Inc. | Jan 27, 20265:33 PM ET | Ringo William RFormer director | 1.17K | $11.5K | Jan 27, 2026 | Fidelity Brokerage Services LLC | SEC |
| MPMP Materials Corp. | Jan 20, 20264:36 PM ET | Elliot HoopsOfficer | 7.82K | $533.6K | Jan 20, 202610b5-1 | Merrill | SEC |
| IOTSamsara Inc. | Jan 15, 20264:04 PM ET | Kirchhoff Benjamin LouisOfficer | 3.41K | $117.9K | Jan 15, 202610b5-1 | Charles Schwab & Co., Inc. | SEC |
| VIRVir Biotechnology, Inc. | Jan 14, 20269:00 PM ET | SVF Endurance (Cayman) LimitedShareholder | 1.25M | $8.53M | Jan 14, 202610b5-1 | BTIG, LLC | SEC |
| ATRAAtara Biotherapeutics, Inc. | Jan 12, 20269:26 PM ET | Panacea Innovation Ltd10% stockholder | 80.6K | $473.7K | Jan 12, 2026 | Cantor Fitzgerald | SEC |
| ADPTAdaptive Biotechnologies Corp | Jan 12, 20264:27 PM ET | Francis LoOfficer | 64.3K | $1.01M | Jan 12, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Jan 12, 20264:26 PM ET | Kyle PiskelOfficer | 11.1K | $174.6K | Jan 12, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTCTPTC Therapeutics, Inc. | Jan 9, 20264:11 PM ET | Boulding Mark ElliottOfficer | 2.31K | $180.3K | Jan 9, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Jan 8, 20264:17 PM ET | Boulding Mark ElliottOfficer | 1.29K | $98.3K | Jan 8, 2026 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Jan 8, 20264:10 PM ET | Boulding Mark ElliottOfficer | 2.75K | $210.4K | Jan 8, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Jan 7, 20264:44 PM ET | Herriot TabuteauOfficer | 31.3K | $5.34M | Jan 7, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Jan 7, 20264:37 PM ET | Boulding Mark ElliottOfficer | 3.38K | $261.4K | Jan 7, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Jan 7, 20264:36 PM ET | Boulding Mark ElliottOfficer | 1.50K | $116.5K | Jan 7, 2026 | Fidelity Brokerage Services LLC | SEC |
| PBYIPuma Biotechnology, Inc. | Jan 7, 20264:28 PM ET | Auerbach Alan HOfficer ยท Director | 18.0K | $105.9K | Jan 7, 2026 | Fidelity Brokerage Services LLC | SEC |
| PBYIPuma Biotechnology, Inc. | Jan 7, 20264:25 PM ET | Hunt Douglas MOfficer | 5.01K | $29.5K | Jan 7, 2026 | Fidelity Brokerage Services LLC | SEC |